24 May 2013
Keywords: Merck & Co, Lycea, Autoimmune diseases, Licensing
Article | 04 March 2011
Pharma giant Merck & Co (NYSE: MRK) has signed a deal with fellow USA-based drug start-up Lycera Corp to discover, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 March 2011
3 March 2011
23 May 2013
© 2013 thepharmaletter.com